The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome

References

• Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism. 2018;86:1–7. doi:10.1016/j.metabol.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Dahan MH, Reaven G. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine. 2019;64(3):685–689. doi:10.1007/s12020-019-01899-9.
   PubMed Web of Science ®Google Scholar
• Karthik S, Vipin VP, Kapoor A, et al. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Hum Reprod. 2019;34(8):1559–1566. doi:10.1093/humrep/dez104.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale Héctor F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. doi:10.1038/nrendo.2018.24.
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592. doi:10.1210/jc.2013-2350.
   PubMed Web of Science ®Google Scholar
• Gleicher N, Darmon S, Patrizio P, et al. Reconsidering the polycystic ovary syndrome (PCOS). Biomedicines. 2022;10(7):1505. doi:10.3390/biomedicines10071505.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(1):16057. doi:10.1038/nrdp.2016.57.
   PubMed Web of Science ®Google Scholar
• Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569. doi:10.1155/2022/9240569.
   PubMed Web of Science ®Google Scholar
• Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109. doi:10.1111/j.1467-789X.2012.01053.x.
   PubMed Web of Science ®Google Scholar
• Ye W, Xie T, Song Y, et al. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021;25(4):1825–1837. doi:10.1111/jcmm.16205.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol. 2024;261(1):e230342. doi:10.1530/JOE-23-0342.
   Web of Science ®Google Scholar
• Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome–part 1. Endocr Pract. 2015;21(11):1291–1300. doi:10.4158/EP15748.DSC.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013;100(1):2–11. doi:10.1016/j.fertnstert.2013.05.023.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Shen S, et al. Association of androgen excess with glucose intolerance in women with polycystic ovary syndrome. Biomed Res Int. 2018;2018:6869705. doi:10.1155/2018/6869705.
   PubMed Web of Science ®Google Scholar
• Xu W, Morford J, Mauvais-Jarvis F. Emerging role of testosterone in pancreatic β-cell function and insulin secretion. J Endocrinol. 2019;240(3):R97–R105. doi:10.1530/JOE-18-0573.
   Web of Science ®Google Scholar
• Sanchez-Garrido Miguel A, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. doi:10.1016/j.molmet.2020.01.001.
   PubMed Web of Science ®Google Scholar
• Tosi F, Dal Molin F, Zamboni F, et al. Serum androgens are independent predictors of insulin clearance but not of insulin secretion in women with PCOS. J Clin Endocrinol Metab. 2020;105(5):dgaa095. doi:10.1210/clinem/dgaa095
   PubMed Web of Science ®Google Scholar
• Stassek J, Erdmann J, Ohnolz F, et al. C-Peptide, baseline and postprandial insulin resistance after a carbohydrate-rich test meal – evidence for an increased insulin clearance in PCOS patients? Geburtshilfe Frauenheilkd. 2017;77(1):59–65. doi:10.1055/s-0042-119199.
   PubMed Web of Science ®Google Scholar
• Couto Alves A, Valcarcel B, Mäkinen V-P, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes (Lond). 2017;41(9):1331–1340. doi:10.1038/ijo.2017.126.
   PubMed Web of Science ®Google Scholar
• Javed Z, Papageorgiou M, Deshmukh H, et al. Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study. Clin Endocrinol (Oxf). 2019;90(6):805–813. doi:10.1111/cen.13968.
   PubMed Web of Science ®Google Scholar
• Guo F, Gong Z, Fernando T, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2022;13:892125. doi:10.3389/fendo.2022.892125.
   PubMed Web of Science ®Google Scholar
• Lazúrová I, Lazúrová Z, Figurová J, et al. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome. Physiol Res. 2019;68(3):457–465. doi:10.33549/physiolres.934062.
   PubMed Web of Science ®Google Scholar